Drug Reference · Updated 2026-05-08

Rybelsus

Brand name for oral semaglutide, FDA-approved for type 2 diabetes mellitus. Daily tablet (3, 7, 14 mg).

By Novo NordiskUpdated 2026-05-08
SS
Editorial team
Dr. Sam Saberian · Lead Medical Researcher
Medical review by Alen A. Schwartz, MD · Edited by Julliana Edwards · Last updated 2026-05-11

Rybelsus overview

Brand name for oral semaglutide, FDA-approved for type 2 diabetes mellitus. Daily tablet (3, 7, 14 mg).

Rybelsus at a glance

Manufacturer
Novo Nordisk
FDA status
FDA-approved

Related pages